Jaklin Gukasyan - Concepedia

Author

Jaklin Gukasyan

Also Known As

J. Gukasyan, Jacklin Gukasyan, Jaklin Gukasyan

Publications

747

Citations

H-Index

Concepts

All Affiliations

Jaklin Gukasyan is an author at University of California, Los Angeles specializing in medicine, oncology, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	641
2	Immunology	2	2	64
3	Pathology	1	1	17
4	Pharmacology	1	1	577
5	Autoimmune Disease	1	1	17

Jaklin Gukasyan

Publications

737

Citations

H-Index

Page 1

	Year	Citations
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman, Journal of Thoracic Oncology Advanced NsclcOncologyMedicineReceptor Tyrosine KinasePhase Ii Study	2018	577
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer Siwen Hu‐Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Clinical Cancer Research	2019	68
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44 Amy L. Cummings, Jaklin Gukasyan, Henry Y. Lu, Nature Cancer Cancer ImmunosurveillanceNon-small-cell Lung CancerMedicineMutational Landscape InfluencesImmunology	2020	47
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer Philippe Rochigneux, Aaron Lisberg, Alejandro J. Garcia, Clinical Cancer Research	2022	28
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC Nanruoyi Zhou, Maria A. Velez, Benjamin Bachrach, Lung Cancer Autoimmune DiseaseThyroid DysfunctionFrequent Event Post-treatmentMedicineThyroid Disease	2021	17

Page 1